Pharmacokinetics of Celebrex for the prevention/treatment of colorectal cancer: Systemic pharmacokinetics and elimination of Celebrex in healthy volunteers
Latest Information Update: 03 Apr 2020
At a glance
- Drugs Celecoxib (Primary)
- Indications Acute pain; Ankylosing spondylitis; Back pain; Cervicobrachial syndrome; Colorectal cancer; Dental pain; Dysmenorrhoea; Familial adenomatous polyposis; Juvenile rheumatoid arthritis; Non-small cell lung cancer; Osteoarthritis; Pain; Periarthritis; Postoperative pain; Rheumatic disorders; Rheumatoid arthritis; Stomatitis; Tendinitis; Tenosynovitis
- Focus Pharmacokinetics
- 03 Apr 2020 Status changed from recruiting to completed.
- 24 Aug 2017 New trial record